These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8740 related articles for article (PubMed ID: 18376462)

  • 1. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment.
    Lassau N; Chami L; Benatsou B; Peronneau P; Roche A
    Eur Radiol; 2007 Dec; 17 Suppl 6():F89-98. PubMed ID: 18376462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments.
    Lassau N; Chami L; Chebil M; Benatsou B; Bidault S; Girard E; Abboud G; Roche A
    Discov Med; 2011 Jan; 11(56):18-24. PubMed ID: 21276407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment.
    Lassau N; Chebil M; Chami L; Bidault S; Girard E; Roche A
    Target Oncol; 2010 Mar; 5(1):53-8. PubMed ID: 20379790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study.
    Lassau N; Chapotot L; Benatsou B; Vilgrain V; Kind M; Lacroix J; Cuinet M; Taieb S; Aziza R; Sarran A; Labbe C; Gallix B; Lucidarme O; Ptak Y; Rocher L; Caquot LM; Chagnon S; Marion D; Luciani A; Uzan-Augui J; Koscielny S
    Invest Radiol; 2012 Dec; 47(12):711-6. PubMed ID: 23095862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography.
    Lassau N; Coiffier B; Faivre L; Benatsou B; Bidault S; Girard E; Asselain B; Pitre-Champagnat S; Koscielny S
    Invest Radiol; 2017 Mar; 52(3):148-154. PubMed ID: 28106614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.
    Lassau N; Bonastre J; Kind M; Vilgrain V; Lacroix J; Cuinet M; Taieb S; Aziza R; Sarran A; Labbe-Devilliers C; Gallix B; Lucidarme O; Ptak Y; Rocher L; Caquot LM; Chagnon S; Marion D; Luciani A; Feutray S; Uzan-Augui J; Coiffier B; Benastou B; Koscielny S
    Invest Radiol; 2014 Dec; 49(12):794-800. PubMed ID: 24991866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imaging and angiogenesis: DCE-US (dynamic contrast enhanced-ultrasonography)].
    Lassau N; Roche A
    Bull Cancer; 2007 Jul; 94 Spec No():S247-53. PubMed ID: 17846011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current events about echography in 2006: position of the ultrasound functional imaging for the early evaluation of targeted therapeutics].
    Lassau N; Chami L; Péronneau P
    Bull Cancer; 2006 Dec; 93(12):1207-11. PubMed ID: 17182377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.
    Dietrich CF; Averkiou MA; Correas JM; Lassau N; Leen E; Piscaglia F
    Ultraschall Med; 2012 Aug; 33(4):344-51. PubMed ID: 22843433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.
    Pitre-Champagnat S; Leguerney I; Bosq J; Peronneau P; Kiessling F; Calmels L; Coulot J; Lassau N
    Invest Radiol; 2015 Apr; 50(4):212-7. PubMed ID: 25275834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound.
    Lamuraglia M; Escudier B; Chami L; Schwartz B; Leclère J; Roche A; Lassau N
    Eur J Cancer; 2006 Oct; 42(15):2472-9. PubMed ID: 16965911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy.
    Guibal A; Taillade L; Mulé S; Comperat E; Badachi Y; Golmard JL; Le Guillou-Buffello D; Rixe O; Bridal SL; Lucidarme O
    Radiology; 2010 Feb; 254(2):420-9. PubMed ID: 20093514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab.
    Lassau N; Coiffier B; Kind M; Vilgrain V; Lacroix J; Cuinet M; Taieb S; Aziza R; Sarran A; Labbe-Devilliers C; Gallix B; Lucidarme O; Ptak Y; Rocher L; Caquot LM; Chagnon S; Marion D; Luciani A; Feutray S; Uzan-Augui J; Benatsou B; Bonastre J; Koscielny S
    Ann Oncol; 2016 Oct; 27(10):1922-8. PubMed ID: 27502701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
    Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
    Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US.
    Zhou JH; Cao LH; Liu JB; Zheng W; Liu M; Luo RZ; Han F; Li AH
    Radiology; 2011 May; 259(2):406-13. PubMed ID: 21292869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of angiogenesis in rabbit orthotropic liver tumors using three-dimensional dynamic contrast-enhanced ultrasound compared with two-dimensional DCE-US.
    Zheng Q; Zhang JC; Wang Z; Ruan SM; Li W; Pan FS; Chen LD; Zhang YC; Wu WX; Xie XY; Lu MD; Shan QY; Wang W
    Jpn J Radiol; 2019 Oct; 37(10):701-709. PubMed ID: 31401722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.
    Peronneau P; Lassau N; Leguerney I; Roche A; Cosgrove D
    Ultraschall Med; 2010 Aug; 31(4):370-8. PubMed ID: 20577941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.
    Leguerney I; Lassau N; Koscielny S; Rodrigues M; Massard C; Rouffiac V; Benatsou B; Thalmensi J; Bawa O; Opolon P; Peronneau P; Roche A
    Invest New Drugs; 2012 Feb; 30(1):144-56. PubMed ID: 20924644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 437.